TruScreen's share purchase plan oversubscribed, raising over NZ$1.6m

Truscreen Group Limited (NZX:TRU) announced that its Share Purchase Plan (SPP), initially announced on May 29, 2025, closed oversubscribed. The SPP raised approximately NZ$1.67 million, equivalent to approximately 83 million shares at NZ$0.02 per share. Combined with the previously announced share placement on June 3, 2025, the company has raised approximately $4 million before costs. The issue price of the SPP shares was NZ$0.02/A$0.01818, representing a 2.5% discount to the 5-day VWAP before the SPP closure. Due to subscriptions exceeding the company's capacity, a shareholder meeting will be held on July 15, 2025, to approve the issuance of up to 26,363,636 shares under the placement and 28,191,169 shares under the SPP, both under Listing Rule 4.2. Shareholder approval is also being sought for share options attaching to each placement and SPP share. Funds raised will support growth in the Chinese market, distribution of Dalton Bio IVD HPV DNA products, public cervical cancer screening programs in Vietnam, Zimbabwe and Uzbekistan, continued development of public screening sales channels and development in Indonesian, ASEAN and Indian markets.